Importer of Controlled Substances Application: United States Pharmacopeial Convention, 47177-47178 [2024-11890]
Download as PDF
<![CDATA[
47177
Federal Register / Vol. 89, No. 106 / Friday, May 31, 2024 / Notices
legitimate scientific medical research
and/or industrial purposes.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–11891 Filed 5–30–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1379]
Importer of Controlled Substances
Application: United States
Pharmacopeial Convention
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
United States Pharmacopeial
Convention has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 1, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 1, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
SUMMARY:
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on April 5, 2024, United
States Pharmacopeial Convention, 7135
English Muffin Way, Frederick,
Maryland 21704, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Methaqualone ..................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
VerDate Sep<11>2014
17:22 May 30, 2024
Jkt 262001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\31MYN1.SGM
31MYN1
1235
1237
2565
7315
7395
7400
7411
9053
9168
9200
9307
9634
1105
1205
1631
1724
2125
2270
2315
2550
7471
8333
8501
9010
9020
9041
9120
9170
9210
9220
9230
9273
9333
9652
9668
9737
9740
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
47178
Federal Register / Vol. 89, No. 106 / Friday, May 31, 2024 / Notices
The company plans to import the
above listed control substances for
distribution as analytical reference
standards to its customers for analytical
testing of raw materials. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–11890 Filed 5–30–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
On May 24, 2024, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the District of Alaska in the
lawsuit entitled United States v. PSF,
Inc., Peter Pan Seafood Company, LLC,
and Silver Bay Seafoods-Valdez, LLC,
Civil Action No. 3:24–cv–00112.
In the Complaint, the United States
alleges that Defendants PSF, Inc., Peter
Pan Seafood Company, LLC, and Silver
Bay Seafoods-Valdez, LLC violated
section 301(a) of the Clean Water Act,
33 U.S.C. 1311(a), by violating the
permit conditions and limitations of the
National Pollutant Discharge
Elimination System (NPDES) permits
issued to Defendants by the U.S.
Environmental Protection Agency and
the Alaska Department of
Environmental Conservation under
section 402(a) of the Clean Water Act,
33 U.S.C. 1342(a) at their respective
facilities in Valdez and King Cove,
Alaska. The proposed Consent Decree
resolves the claims in the Complaint
with covenants not to sue, in return for
injunctive relief and $750,000 in civil
penalties.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. PSF, Inc., Peter Pan
Seafood Company, LLC, and Silver Bay
Seafoods-Valdez, LLC, D.J. Ref. No. 90–
5–1–1–12463. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
VerDate Sep<11>2014
17:22 May 30, 2024
Jkt 262001
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
Any comments submitted in writing
may be filed in whole or in part on the
public court docket without notice to
the commenter.
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
Consent Decree, you may request
assistance by email or by mail to the
addresses provided above for submitting
comments.
Kathryn C. Macdonald,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–11975 Filed 5–30–24; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On May 21, 2024, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Eastern District of Texas in
the lawsuit entitled United States of
America v. TPC Group LLC, Civil Action
No. 24–00187.
In this action, the United States, on
behalf of the U.S. Environmental
Protection Agency, filed a Complaint
and proposed Consent Decree against
TPC Group LLC (TPC Group) for
violating the chemical accident
prevention provisions of the Clean Air
Act (‘‘CAA’’) at TPC Group’s
petrochemical manufacturing facilities
in Port Neches and Houston, Texas.
This case stems in part from a
November 27, 2019, explosion at TPC
Group’s Port Neches facility that
resulted in the evacuations of thousands
of residents from the City of Port Neches
and surrounding areas, released more
than 11 million pounds of extremely
hazardous substances, caused more than
$130 million in offsite property damage,
and resulted in other impacts to human
health and the environment. In the
Complaint, the United States alleges
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
numerous violations of section 112(r) of
the CAA, 42 U.S.C. 7412(r), against TPC
Group at its Port Neches facility,
including those related to the 2019
explosion. The complaint also alleges
numerous violations of Section 112(r) of
the CAA, 42 U.S.C. 7412(r), at TPC
Group’s Houston facility, including
failing to promptly take corrective
actions for hundreds of pieces of
process equipment and failing to
address conditions similar to those that
led to the Port Neches explosions.
Under the proposed Consent Decree,
TPC Group will pay $12.1 million in
civil penalties to be paid through TPC
Group’s bankruptcy proceedings. TPC
Group will also spend approximately
$80 million to improve its risk
management program and improve
safety at both facilities.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States of America v. TPC
Group LLC, D.J. Ref. No. 90–5–2–1–
12550. All comments must be submitted
no later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
Any comments submitted in writing
or at a public meeting may be filed in
whole or in part on the public court
docket without notice to the commenter.
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
proposed Consent Decree, you may
request assistance by email or by mail
to the addresses provided above for
submitting comments.
Thomas Carroll,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–11881 Filed 5–30–24; 8:45 am]
BILLING CODE 4410–15–P
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 89, Number 106 (Friday, May 31, 2024)]
[Notices]
[Pages 47177-47178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11890]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1379]
Importer of Controlled Substances Application: United States
Pharmacopeial Convention
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: United States Pharmacopeial Convention has applied to be
registered as an importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 1, 2024. Such persons may also file a written request for a
hearing on the application on or before July 1, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on April 5, 2024, United States Pharmacopeial
Convention, 7135 English Muffin Way, Frederick, Maryland 21704, applied
to be registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................ 1235 I
Methcathinone............................ 1237 I
Methaqualone............................. 2565 I
Lysergic acid diethylamide............... 7315 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
3,4-Methylenedioxyamphetamine............ 7400 I
4-Methoxyamphetamine..................... 7411 I
Codeine-N-oxide.......................... 9053 I
Difenoxin................................ 9168 I
Heroin................................... 9200 I
Morphine-N-oxide......................... 9307 I
Norlevorphanol........................... 9634 I
Methamphetamine.......................... 1105 II
Lisdexamfetamine......................... 1205 II
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Phencyclidine............................ 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II
Phenylacetone............................ 8501 II
Alphaprodine............................. 9010 II
Anileridine.............................. 9020 II
Cocaine.................................. 9041 II
Dihydrocodeine........................... 9120 II
Diphenoxylate............................ 9170 II
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Thebaine................................. 9333 II
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Alfentanil............................... 9737 II
Sufentanil............................... 9740 II
------------------------------------------------------------------------
[[Page 47178]]
The company plans to import the above listed control substances for
distribution as analytical reference standards to its customers for
analytical testing of raw materials. No other activities for these drug
codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-11890 Filed 5-30-24; 8:45 am]
BILLING CODE P
